Cited by 575Antifungal resistance and susceptibilityBacterial biofilms and quorum sensingFungal and yeast genetics research

Candida biofilms on implanted biomaterials: a clinically significant problem

Ramage, Gordon, Martínez, José Pedro, López-Ribot, José Luis·2006·FEMS Yeast Research

Abstract

In recent years there has been an increasing appreciation that microbial biofilms are ubiquitous, which has resulted in a number of studies on infectious diseases from a biofilm perspective. Biofilms are defined as structured microbial communities that are attached to a surface and encased in a matrix of exopolymeric material. A wide range of biomaterials used in clinical practice have been shown to support colonization and biofilm formation by Candida spp., and the increase in Candida infections in the last decades has almost paralleled the increase and widespread use of a broad range of medical implant devices, mainly in populations with impaired host defenses. Formation of Candida biofilms has important clinical repercussions because of their increased resistance to antifungal therapy and the ability of cells within biofilms to withstand host immune defenses. Further recognition and understanding of the role of Candida biofilms in human infection should help in the clinical management of these recalcitrant infections.

Integrity signals

Registry

Crossref · 10.1111/j.1567-1364.2006.00117.x

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Candida biofilms afford fungal cells a safe haven, constitute reservoirs for persistent sources of candidiasis, and can negatively affect the function of implanted devices.

    “In addition, Candida biofilms afford fungal cells a safe haven, constitute reservoirs for persistent sources of candidiasis, and can also negatively affect the function of implanted devices [29].”
  • These biofilms exhibit greatly increased resistance to antifungal agents and an enhanced ability to withstand host immune defenses.

    “These biofilms exhibit greatly increased resistance to antifungal agents and an enhanced ability to withstand host immune defenses21.”
  • A well-documented virulence factor of Candida species is the notable ability to form adherent structures, known as biofilms, on surfaces of medical devices.

    “A well-documented virulence factor of Candida species is the notable ability to form adherent structures, known as biofilms, on surfaces of medical devices [49–51].”
  • Candida dubliniensis, Candida parapsilosis, Candida tropicalis, and Candida krusei have all been implicated in biofilm-associated infections.

    “The closely related species Candida dubliniensis, Candida parapsilosis, Candida tropicalis, and Candida krusei have all been implicated in biofilm-associated infections (73, 157, 187).”

    From <i>Candida albicans</i> Biofilms and Human Disease (2015) · cites this paper as [157]

  • Candida glabrata forms thin biofilms in vitro without hyphal cells on biotic and abiotic surfaces associated with the human host.

    “Candida glabrata (which, despite the name, lies well outside the CTG clade phylogenetically) forms thin biofilms in vitro (without hyphal cells) on biotic and abiotic surfaces associated with the human host (157).”

    From <i>Candida albicans</i> Biofilms and Human Disease (2015) · cites this paper as [157]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ramage, G., Martínez, J. P., & López-Ribot, J. L.
Affiliations
  • Glasgow Caledonian University (GB)
  • Universitat de València (ES)
Venue
FEMS Yeast Research
Published
2006-11
Volume
6
Issue
7
Pages
979-986
ISSN
  • 1567-1356 (ISSN-L)
  • 1567-1364
OpenAlex
W2126155024
Cited by
575
References
82
Citations by year
2026: 16 · 2025: 23 · 2024: 16 · 2023: 24 · 2022: 19 · 2021: 34 · 2020: 37 · 2019: 28 · 2018: 36 · 2017: 37 · 2016: 35 · 2015: 43 · 2014: 38 · 2013: 42 · 2012: 34
FWCI
2.02
Type
journal article
Language
en
Open access
closed
Locations
  • FEMS Yeast Research (publishedVersion)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
  • ResearchOnline (submittedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Keywords
Candida biofilms, medical device-related infections, implant materials, antifungal resistance, exopolysaccharide matrix, host immune evasion
MeSH terms
Candida, Catheterization, Central Venous, Catheters, Indwelling, Dentures, Equipment and Supplies, Renal Dialysis, Humans, Biofilms, Prostheses and Implants

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review